Jounce Therapeutics Inc buy Slaandjivaa
Start price
14.03.17
/
50%
€19.65
Target price
24.03.17
€25.26
Performance (%)
17.43%
End price
24.03.17
€23.07
Summary
This prediction ended on 24.03.17 with a price of €23.07. The prediction had a final performance of 17.43%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Jounce Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -1.499% | 7.705% | 5.243% | 46.958% |
| iShares Nasdaq 100 | 1.380% | 16.275% | 36.094% | 95.841% |
| iShares Nikkei 225® | -1.992% | 13.113% | 40.183% | 62.915% |
| iShares S&P 500 | 0.345% | 10.816% | 26.473% | 67.253% |
Comments by Slaandjivaa for this prediction
In the thread Jounce Therapeutics Inc diskutieren
Unschlaff
Achten:
http://seekingalpha.com/article/4054590-buy-shares-lesser-known-celgene-partner
(Vom Mitglied beendet)


